{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-25-011991","form_type":"8-K","ticker":"MDCX","cik":"0001997296","company_name":"Medicus Pharma Ltd.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.658360+00:00","generated_at":"2026-05-19T02:00:55.632624+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Medicus Pharma issues third debenture for $2.5M, completing $5M Yorkville facility","bullets":["On June 17, 2025, issued third debenture to YA II PN, Ltd. for $2.5M principal, net proceeds $2.25M.","Total aggregate principal from three debentures now $5M; net proceeds to Company $4.5M.","Debentures bear 8% annual interest (18% upon default), mature February 2, 2026, guaranteed by subsidiaries."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-25-011991","json":"https://secwatch.observer/filing/0001062993-25-011991.json","markdown":"https://secwatch.observer/filing/0001062993-25-011991.md","text":"https://secwatch.observer/filing/0001062993-25-011991.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325011991/0001062993-25-011991-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325011991/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T02:00:55.632624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f5a83c10f2c4a1a6aed6bee19730326f74a64af3","claim":"Medicus Pharma Ltd. incurred credit facility of $2,500,000 with YA II PN, Ltd. at 8.00% per annum, subject to a potential increase to 18.00% per annum upon the oc maturing February 2, 2026.","evidence_excerpt":"On June 17, 2025, Yorkville purchased and the Company issued a third Debenture in aggregate principal amount of $2,500,000, such amount being the remaining amount available pursuant to the Purchase Agreement, for net proceeds to the Company of $2,250,000","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325011991/0001062993-25-011991-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"$2,500,000"},{"label":"Counterparty","value":"YA II PN, Ltd."},{"label":"Rate","value":"8.00% per annum, subject to a potential increase to 18.00% per annum upon the oc"},{"label":"Maturity","value":"February 2, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}